Click here to read the articles and download the PDF

Pharmaceutical Commerce - December 2024

Because of the potential for product shortages at pharmacies, the FDA has not only given industry more time for compliance—but time to catch up on boosting the supply chain’s interoperable efforts.

Did Industry Fumble the DSCSA Deadline?

A crash course on the bubble itself, including therapeutic areas most affected.

Going Inside the Gross-to-Net Bubble and Its Nuances

Addressing the bottlenecks in cell and gene therapy manufacturing through a well-designed artificial intelligence approach is essential to avoiding data siloes.

Why AI Advances in CGT Require Getting Data Right

Articles

The program recognizes organizations that prioritize the highest standards of care when it comes to the handling and transportation of goods in the healthcare space.

DeSpir Logistics Officially Accredited by HDA, PCSC Good Distribution Practices Accreditation Program

The new products offer more temperature control and sustainability benefits.

Thermo Fisher Scientific Introduces New Ultra-Low Temperature Freezer

Videos

In an interview with Pharma Commerce Editor Nicholas Saraceno, Ed Schoonveld, Value & Access Advisor, Schoonveld Advisory, offers his thoughts on lower drug prices in the US and provides a sneak peak into future PC features. 

Ed Schoonveld Discusses Drug Pricing in the US and Upcoming Articles

The latest news for pharma industry insiders.

Pharma Pulse 4/8/24: Cannabis Use in Oncology, J&J to Acquire Shockwave Medical & more

The program intends to address pharmacy deserts, which are predominantly found in underserved communities.  

McKesson Debuts Project Oasis to Increase Patient Accessibility to Pharmacies

The first commercial shipments are scheduled for mid-April.

Logistics4Pharma Unveils Dry Shipper with -196°C Storage Capabilities

Pharma Pulse 4/5/24: Is 2024 the Year for Psychedelic Medicine? Barriers Impacting Enrollment in Lung Cancer Trials & more

In an interview with Pharma Commerce Editor Nicholas Saraceno, Ed Schoonveld, Value and Access Advisor, Schoonveld Advisory and author of The Price of Global Health, explains why pharmaceutical products tend to cost more in the US than the rest of the world. 

Ed Schoonveld Discusses List Prices for Pharmaceuticals in the US Compared to Other Countries

Although AI has simplified various market access processes, this technology does also present its share of barriers, so what can be done to find a happy medium? 

The Synergies in Combining Artificial Intelligence and Market Access 

Year-on-year growth in demand is strong, according to the IATA.

Featured Content

Pharmaceutical Commerce - December 2024

Did Industry Fumble the DSCSA Deadline?

Going Inside the Gross-to-Net Bubble and Its Nuances

Why AI Advances in CGT Require Getting Data Right